1 Jul 2020 12:30
REDX PHARMA PLC
("Redx" or "the Company")
Share Purchases by Directors
Alderley Park, 1 July 2020 - Redx Pharma (AIM:REDX), the drug discovery and development Group focused on cancer and fibrosis, announces that it has been notified that Iain Ross, Non-executive Chairman, has on Tuesday 30 June acquired 215,870 Redx ordinary shares at the following prices:
Number of Ordinary shares purchased | Price per share (pence) |
86,881 | 17.25 |
53,989 | 18.50 |
35,000 | 19.75 |
40,000 | 22.50 |
Following this, Mr Ross will hold 215,870 ordinary shares in the Company, representing 0.11 per cent. of the issued share capital.
The Company also announces that Non-Executive Director Mr Peter Presland has on Tuesday 30 June acquired 118,849 Redx ordinary shares at a price of 25 pence per share. Mr Presland purchased the shares through his self-invested personal pension (SIPP). Following this, Mr Presland will hold 118,849 ordinary shares in the Company, representing 0.06 per cent of the issued share capital.
-Ends-
For further information, please contact:
Redx Pharma Plc | T: +44 1625 469 918 |
Lisa Anson, Chief Executive Officer James Mead, Chief Financial Officer |
|
|
|
SPARK Advisory Partners (Nominated Advisor) | T: +44 203 368 3550 |
Matt Davis/ Henry Todd |
|
|
|
WG Partners LLP (Broker) | T: +44 20 3705 9330 |
Claes Spång/ Chris Lee/ David Wilson |
|
|
|
|
|
FTI Consulting | T: +44 20 3727 1000 |
Simon Conway/Ciara Martin |
|
About Redx Pharma Plc
Redx is a UK biotechnology Group whose shares are traded on AIM (AIM:REDX). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a. | Name | Iain Ross |
2 | Reason for notification |
|
a. | Position/Status | Non -Executive Chairman |
b. | Initial notification/ Amendment | Initial Notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a. | Name | Redx Pharma Plc |
b. | LEI | 213800HMS4EBXO589Y37 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares of 1p each ISIN: GB00BSNB6S51 |
b. | Nature of the transaction | Purchase |
c. | Price(s) and volume(s) | 86,881 at 17.25 pence per share 53,989 at 18.50 pence per share 35,000 at 19.75 pence per share 40,000 at 22.50 pence per share |
d. | Aggregated information - Aggregated Volume - Price | 215,870 at 18.94 pence per share |
e. | Date of the transaction | 30/06/20 |
f. | Place of the transaction | Outside of trading venue |
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a. | Name | Peter Presland |
2 | Reason for notification |
|
a. | Position/Status | Non-executive Director |
b. | Initial notification/ Amendment | Initial Notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a. | Name | Redx Pharma Plc |
b. | LEI | 213800HMS4EBXO589Y37 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares of 1p each ISIN: GB00BSNB6S51 |
b. | Nature of the transaction | Purchase |
c. | Price(s) and volume(s) | 118,849
25 pence |
d. | Aggregated information - Aggregated Volume - Price | N/A - Single Transaction |
e. | Date of the transaction | 30/06/20 |
f. | Place of the transaction | Outside of trading venue |